Ignite Creation Date:
2024-05-06 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 12:48 PM
Study NCT ID:
NCT03571360
Status:
UNKNOWN
Last Update Posted:
2020-06-11
First Post:
2018-06-12
Brief Title:
CTA ExpressionMethylation and Response to Pembrolizumab of NSCLC Patients
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Organization Data
Organization:
Medical University of Vienna
Class:
OTHER
Study ID:
2017-000689-30
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medical University of Vienna
Lead Sponsor Class:
OTHER
Responsible Party:
Gerwin Heller
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Medical University of Vienna
Old Name:
None
Old Organization:
None